Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2019.1648430
Abstract: ABSTRACT Introduction: A PEGylated form of irinotecan, a topoisomerase I inhibitor, is now available in commerce; its safety and efficacy have been tested in platinum resistant/refractory ovarian cancer (PROC) patients. This novel agent is known… read more here.
Keywords: etirinotecan pegol; ovarian cancer; refractory ovarian; platinum resistant ... See more keywords
The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1323619
Abstract: ABSTRACT Purpose: DNA demethylating agents have shown clinical effectiveness in hematological and solid tumors. This trial tested the safety, efficacy, and treatment outcomes of decitabine-based chemotherapy or combined with immunotherapy in recurrent ovarian cancer patients.… read more here.
Keywords: platinum resistant; treatment; ovarian cancer; resistant refractory ... See more keywords
1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1389
Abstract: Abstract Background Resistant or refractory CMV infections are not well defined and may be associated with high morbidity and mortality in allogeneic hematopoietic cell transplant (allo-HCT) recipients. Suspicion of resistant CMV infections is usually based… read more here.
Keywords: cmv; cmv infections; mortality; refractory cmv ... See more keywords
Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Hypertension"
DOI: 10.1097/hjh.0000000000002441
Abstract: OBJECTIVES To assess the prevalence of primary aldosteronism and its association with cardiometabolic complications in patients with resistant and refractory hypertension. METHODS One hundred and ten consecutive patients with true resistant hypertension [insufficient blood pressure… read more here.
Keywords: refractory hypertension; resistant refractory; patients resistant; hypertension ... See more keywords
Evaluating the Safety of Maribavir for the Treatment of Cytomegalovirus
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s303052
Abstract: Purpose of Review Cytomegalovirus (CMV) infections are a common complication in solid organ (SOT) and hematopoietic stem cell transplant (HSCT) recipients, leading to increased morbidity and mortality. Currently available treatment options have reduced the burden… read more here.
Keywords: therapy; resistant refractory; phase; cmv ... See more keywords